From: Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration
Case | MAPT variant | MAPT isoform | Sex | Age onset (yrs) | Age death (yrs) | Disease duration (yrs) | Group | FTLD-CDR | Clinical diagnosis | PMI (hrs) | Brain weight (g) | Co-pathology |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | L315R | 3R + 4R | F |  | 68 |  | Early-stage | 0 |  | 6 | 1188 | Age-related tau (B2) |
2 | P301L | 4R | F | Â | 59 | Â | Early-stage | 0.5 | MCBMIa | 6 | 1079 | Â |
3 | G272V | 3R | M | 43 | 45 | 2 | Early-stage | 1 | bvFTD | 6 | 1495 | Â |
4 | P301L | 4R | M | 49 | 52 | 3 | Intermediate-stage | 2 | bvFTD | 12 | 1115 | Â |
5 | P301L | 4R | M | 53 | 55 | 2 | Intermediate-stage | 2 | bvFTD | 4 | 1100 | Â |
6 | G272V | 3R | F | 47 | 54 | 7 | Intermediate-stage | 2 | bvFTD | 8 | 1027 | Â |
7 | L315R | 3R + 4R | F | 54 | 63 | 9 | End-stage | 3 | bvFTD | 4 | 758 |  |
8 | L315R | 3R + 4R | M | 52 | 57 | 5 | End-stage | 3 | bvFTD | 8 | 1111 |  |
9 | P301L | 4R | M | 58 | 66 | 8 | End-stage | 3 | bvFTD | 5 | 1011 | Â |
10 | P301L | 4R | M | 39 | 46 | 7 | End-stage | 3 | bvFTD | 6 | 1065 | Â |
11 | P301L | 4R | F | 56 | 66 | 10 | End-stage | 3 | bvFTD | 7 | 707 | Â |
12 | P301L | 4R | M | 51 | 60 | 9 | End-stage | 3 | bvFTD | 5 | 887 | Â |
13 | P301L | 4R | F | 50 | 64 | 14 | End-stage | 3 | bvFTD | 8 | 652 | Â |
14 | P301L | 4R | M | 52 | 64 | 12 | End-stage | 3 | bvFTD | 6 | 1029 | Â |
15 | P301L | 4R | M | 53 | 57 | 4 | End-stage | 3 | bvFTD | 5 | 1197 | Vascular (infarcts)b |
16 | P301L | 4R | M | 57 | 65 | 8 | End-stage | 3 | bvFTD | 6 | 1002 | Â |
17 | G272V | 3R | F | 45 | 54 | 9 | End-stage | 3 | bvFTD | 6 | 791 | Â |
18 | G272V | 3R | F | 47 | 67 | 20 | End-stage | 3 | bvFTD | 4 | 757 | Â |
19 | G272V | 3R | M | 41 | 49 | 8 | End-stage | 3 | bvFTD | 5 | 1188 | Beta-amyloid (A1, C0) |
20 | G272V | 3R | M | 42 | 51 | 9 | End-stage | 3 | bvFTD | 4 | 962 | Vascular (ischemic scars)c |
21 | G272V | 3R | M | 42 | 49 | 7 | End-stage | 3 | bvFTD | 5 | 1105 | Â |